InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Explore the detailed record of transactions filed by Matsuda Masaru, See Remarks. Director active across 2 companies, notably Arcutis Biotherapeutics, Inc.. In total, 12 filings have been recorded. Total volume traded: €723k. The latest transaction was disclosed on 4 May 2026 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations12 total
US$146,7197,372 shares@ US$19.90230.0055% mcap40.6% of flow
Common Stock
SEC:0001798679-26-000002·
€146,7197,372 shares@ €19.90230.0055% mcap20.3% of flow
Common Stock
SEC:0001798679-26-000002:0·
037,000 shares0
Common Stock
SEC:0001628280-26-014326·
037,000 shares0
Common Stock
SEC:0001628280-26-014326:0·
US$171,7877,983 shares@ US$21.51910.0064% mcap47.5% of flow
Common Stock
SEC:0001628280-26-005582·
€171,7877,983 shares@ €21.51910.0064% mcap23.7% of flow
Common Stock
SEC:0001628280-26-005582:0·
US$43,1771,657 shares@ US$26.05710.0016% mcap11.9% of flow
Common Stock
SEC:0001798679-25-000007·
€43,1771,657 shares@ €26.05710.0016% mcap6.0% of flow
Common Stock
SEC:0001798679-25-000007:0·
04,875 shares0
Common Stock
SEC:0001567619-22-012149:0·
013,300 shares0
Common Stock
SEC:0001567619-22-006496:0·
06,883 shares0
Common Stock
SEC:0001179110-21-008662·
06,883 shares0
Common Stock
SEC:0001179110-21-008662:0·
12 of 12 declarations
About Matsuda Masaru
Masaru Matsuda is involved in various functions at Arcutis Biotherapeutics, Inc. and Halozyme Therapeutics, Inc. His role includes specific responsibilities that contribute to the development and strategy of the companies. His expertise is an asset to the organization.
